Header cover image

Canadian (TSX) Life Sciences Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies5
  • 7D2.9%
  • 3M-15.8%
  • 1Y-10.1%
  • YTD-39.1%

Over the last 7 days, the Life Sciences industry has risen 2.9%, driven by gains from ImmunoPrecise Antibodies of 10%. Meanwhile, Rapid Dose Therapeutics actually underperformed within the industry, shrinking 8.3% in the last week. However, the industry is down 10% over the past year.

Industry Valuation and Performance

Has the Canadian Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 01 Dec 2021CA$279.2mCA$21.0m-CA$14,997,109.0025.9x
Fri, 29 Oct 2021CA$252.5mCA$20.7m-CA$14,899,797.0025.2x
Sun, 26 Sep 2021CA$243.2mCA$20.7m-CA$11,409,216.0021.1x
Tue, 24 Aug 2021CA$240.3mCA$20.7m-CA$11,409,216.0020.4x
Wed, 30 Jun 2021CA$217.1mCA$19.8m-CA$8,728,216.0022.5x
Sat, 03 Apr 2021CA$240.0mCA$18.6m-CA$3,008,537.0027.5x
Tue, 05 Jan 2021CA$335.5mCA$17.9m-CA$2,477,523.0070.2x
Fri, 09 Oct 2020CA$233.3mCA$16.1m-CA$3,428,320.00169x
Thu, 02 Jul 2020CA$124.3mCA$15.0m-CA$4,969,536.00n/a
Sun, 05 Apr 2020CA$51.0mCA$12.6m-CA$7,843,897.00n/a
Wed, 08 Jan 2020CA$72.2mCA$12.2m-CA$25,037,278.00n/a
Tue, 01 Oct 2019CA$91.7mCA$12.7m-CA$23,070,665.0092.3x
Fri, 05 Jul 2019CA$105.9mCA$11.9m-CA$21,794,476.00n/a
Mon, 08 Apr 2019CA$108.0mCA$10.9m-CA$17,437,548.00n/a
Thu, 10 Jan 2019CA$118.9mCA$10.0m-CA$9,158,301.00n/a
PE Ratio

n/a

Total Market Cap: CA$49.6mTotal Earnings: -CA$6,128,305.00Total Revenue: CA$9.9m0%0%0%3 Year10 Year
201920202021

Current Industry PE: There is only one profitable company in this industry, so there is insufficient data to make an industry-wide assessment of PE.

Past Earnings Growth: The earnings for companies in the Life Sciences industry have deteriorated over the last three years, while revenues for these companies have grown 28% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Canadian Life Sciences industry?

Clinical Research and Equipment2.86%

Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry even though it's trading below its 3-year average PE ratio of 70.2x. This is likely because analysts are expecting annual earnings growth of 2.2% and investors are willing to pay a premium for that growth.

Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 2.2% over the next 5 years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
IPA ImmunoPrecise Antibodies12.3%+CA$16.1m-24.4%PS7.8x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News